Get the Daily Brief
Latest Biotech News
Novel Nanoneedle Patch Offers Painless Alternative to Tissue Biopsies
Scientists at King’s College London have developed a nanoneedle patch containing tens of millions of microscopic silicon needles, thousands of times thinner than a human hair, that collects...
AI-Powered Technologies Advance Drug Development and Diagnostics
Several AI-driven innovations are propelling biotech forward. CSPC Pharmaceutical and AstraZeneca launched a $5.3 billion preclinical drug R&D collaboration leveraging CSPC’s AI drug discovery...
NIH Funds Research into PFAS Impact on Male Reproductive Health
A new two-year research initiative funded by the NIH’s National Institute of Environmental Health Sciences is investigating molecular mechanisms by which per- and polyfluoroalkyl substances (PFAS)...
Advances in Neonatal Cardiorespiratory and Lung Disease Research
Recent studies reveal critical insights into neonatal health. Researchers demonstrated that transcatheter closure of patent ductus arteriosus (PDA) in preterm infants significantly improves...
AI Innovations Enhance Clinical and Wildlife Monitoring
New AI methodologies demonstrate impact across diverse biomedical and ecological areas. At Emory University, a first-in-human trial employing dissolvable microarray patches for rotavirus...
Regulatory and Funding Landscape Shifts in Biotech R&D
Biotech regulation and financing are evolving amid innovation and institutional adjustments. The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) implemented new postmarket...
CRISPR Patent Dispute Rekindled by Appeals Court
The University of California and University of Vienna secured a court ruling that has revived their challenge for key patents on CRISPR–Cas9 gene-editing technology, originally awarded to the...
Sarepta Gene Therapy Halted After Second Liver Failure Death
Sarepta Therapeutics has suspended shipments of its Duchenne muscular dystrophy gene therapy, Elevidys, specifically for non-ambulatory patients following a second fatal case of acute liver...
Supernus Acquires Sage Therapeutics for Up to $795 Million
Supernus Pharmaceuticals is acquiring Sage Therapeutics, a central nervous system-focused biotech, for approximately $561 million upfront with potential milestone payments elevating the deal value...
Innovations in AI and Machine Learning for Biotech Applications
Artificial intelligence continues to drive transformative advances in biotech. At the BIO 2025 AI Summit, industry leaders highlighted both rapid growth and the nascent, evolving nature of AI in...
New Imaging and Diagnostic Technologies Address Medical Challenges
Recent technology breakthroughs promise enhanced diagnostic power and patient care. Researchers at King’s College London developed a nanoneedle patch with tens of millions of microscopic needles...
New Therapeutic Strategies and Drug Development Updates
Recent advancements in drug discovery and development highlight innovative therapeutic strategies. Swedish researchers introduced a dual antioxidant enzyme inhibition approach to induce...
Advances in CRISPR and Gene Editing Technologies
Innovative developments in gene editing continue to expand therapeutic possibilities. The University of California and University of Vienna secured a court ruling to reconsider the CRISPR–Cas9...
Environmental and Ecological Research Insights
Emerging environmental research highlights critical ecosystem and climate dynamics. A team from the Catholic University of the Sacred Heart identified soil bacteria in Italy’s Veneto region...
Breakthroughs in Biomedical Imaging and Computational Tools
Novel computational and imaging tools are enhancing biomedical research precision. Virginia Commonwealth University launched TACIT, a machine learning algorithm that accelerates cell type...
New Materials and Robotics for Medical and Technology Applications
Researchers are pioneering materials and robotic systems to advance medical and industrial technologies. MIT engineers developed a compact, low-power receiver chip extremely resistant to...
Supernus Acquires Sage Therapeutics for Up to $795 Million
Supernus Pharmaceuticals has agreed to acquire Sage Therapeutics for approximately $561 million upfront, with additional contingent payments potentially raising the total to $795 million. The...
FDA Faces Resource Strains Leading to Review Delays
The FDA is experiencing ongoing resource constraints impacting its ability to meet drug approval deadlines. Commissioner Marty Makary has proposed consolidations of administrative functions to...
Sarepta Halts Duchenne Gene Therapy Shipments After Second Patient Death
Sarepta Therapeutics has suspended shipments of its Duchenne muscular dystrophy gene therapy Elevidys for non-ambulatory patients following a second death due to acute liver failure. Both...
Advances in AI-Driven Medical Imaging and Diagnostics
Innovations in artificial intelligence are transforming medical diagnostics with breakthroughs in tumor segmentation and imaging genomics. Researchers in Tokyo developed MHP-Net, an AI model that...